NOVO-B.CO vs. ABT
Compare and contrast key facts about Novo Nordisk A/S (NOVO-B.CO) and Abbott Laboratories (ABT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NOVO-B.CO or ABT.
Correlation
The correlation between NOVO-B.CO and ABT is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NOVO-B.CO vs. ABT - Performance Comparison
Key characteristics
NOVO-B.CO:
-0.74
ABT:
1.00
NOVO-B.CO:
-0.85
ABT:
1.58
NOVO-B.CO:
0.88
ABT:
1.19
NOVO-B.CO:
-0.63
ABT:
0.75
NOVO-B.CO:
-1.37
ABT:
2.36
NOVO-B.CO:
21.30%
ABT:
8.14%
NOVO-B.CO:
39.78%
ABT:
19.13%
NOVO-B.CO:
-64.64%
ABT:
-45.66%
NOVO-B.CO:
-41.87%
ABT:
0.00%
Fundamentals
NOVO-B.CO:
DKK 2.61T
ABT:
$229.17B
NOVO-B.CO:
DKK 22.65
ABT:
$7.64
NOVO-B.CO:
26.38
ABT:
17.29
NOVO-B.CO:
1.19
ABT:
2.34
NOVO-B.CO:
DKK 290.40B
ABT:
$30.98B
NOVO-B.CO:
DKK 245.88B
ABT:
$17.29B
NOVO-B.CO:
DKK 108.58B
ABT:
$7.89B
Returns By Period
In the year-to-date period, NOVO-B.CO achieves a -4.63% return, which is significantly lower than ABT's 18.35% return. Over the past 10 years, NOVO-B.CO has outperformed ABT with an annualized return of 16.89%, while ABT has yielded a comparatively lower 13.07% annualized return.
NOVO-B.CO
-4.63%
3.78%
-35.40%
-27.55%
24.51%
16.89%
ABT
18.35%
14.03%
19.99%
15.29%
10.75%
13.07%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NOVO-B.CO vs. ABT — Risk-Adjusted Performance Rank
NOVO-B.CO
ABT
NOVO-B.CO vs. ABT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOVO-B.CO) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NOVO-B.CO vs. ABT - Dividend Comparison
NOVO-B.CO's dividend yield for the trailing twelve months is around 1.66%, less than ABT's 1.68% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOVO-B.CO Novo Nordisk A/S | 1.66% | 1.59% | 1.01% | 2.09% | 1.27% | 2.02% | 2.11% | 2.64% | 2.27% | 3.69% | 1.25% | 1.73% |
ABT Abbott Laboratories | 1.68% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
Drawdowns
NOVO-B.CO vs. ABT - Drawdown Comparison
The maximum NOVO-B.CO drawdown since its inception was -64.64%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for NOVO-B.CO and ABT. For additional features, visit the drawdowns tool.
Volatility
NOVO-B.CO vs. ABT - Volatility Comparison
Novo Nordisk A/S (NOVO-B.CO) has a higher volatility of 11.84% compared to Abbott Laboratories (ABT) at 7.52%. This indicates that NOVO-B.CO's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NOVO-B.CO vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities